Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study

SUMMARY: This registry-based study of 3068 patients with osteoporosis compared the anti-fracture effectiveness of denosumab versus bisphosphonates. Denosumab was associated with significantly greater risk reduction than alendronate or ibandronate for vertebral and any fractures. No difference in fra...

Descripción completa

Detalles Bibliográficos
Autores principales: Everts-Graber, Judith, Bonel, Harald, Lehmann, Daniel, Gahl, Brigitta, Häuselmann, HansJörg, Studer, Ueli, Ziswiler, Hans-Rudolf, Reichenbach, Stephan, Lehmann, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579111/
https://www.ncbi.nlm.nih.gov/pubmed/37493978
http://dx.doi.org/10.1007/s00198-023-06863-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10579111/
https://www.ncbi.nlm.nih.gov/pubmed/37493978
http://dx.doi.org/10.1007/s00198-023-06863-y

Ejemplares similares